Peripheral arterial disease (PAD) is a growing public health burden. PAD leads to arterial 63 stenosis and consequently inadequate blood flow to the peripheries. 1, 2 This commonly 64 presents as pain in the lower limb(s) precipitated by exercise and relieved by rest, 3 defined as 65 intermittent claudication (IC). Patients with IC experience functional decline and limitation in 66 physical activity (PA), 4 further raising the risk of a cardiovascular event in a vascular system 67 already compromised by the underlying atherosclerosis. 1, 3 Therefore , patients with PAD 68 present with an increased risk of cardiovascular and cerebrovascular events similar to those 69 with coronary heart disease. 5 
70
Lower daily PA levels have been recognised as a strong predictor of increased morbidity and 71 mortality in this population. 6 Supervised exercise programmes (SEPs) are recommended as a 72 primary therapy for this population, 7 and have been shown to improve treadmill walking 73 distances of patients with IC. 8, 9 However, most studies reporting such improvements did not 74 investigate daily PA, and those that have, did not find improvements in daily PA. 9 Reduced 75 self-efficacy, attributed to poor understanding of the disease and uncertainty regarding the 76 importance of walking has been identified as a major barrier to exercise uptake in this 77 population. 10, 11 These findings suggest that a patient-centred self-management approach to 78 improving PA, including structured patient education, may be beneficial in this population. 79
Although current literature supports educating patients with IC about their disease pathology 80 and the importance of walking, 10,11 neither evidence of effectiveness nor patients' perceptions 81 of interventions have been established. The aim of this review is to examine the effect of 82 patient education for improving PA in individuals with PAD and IC and the experiences and 83 perceptions of patients of these interventions. 84
Methods 86
The protocol for this review was registered with the International Prospective Register of 87 Systematic Reviews (CRD42015027314), and has been published elsewhere. 12 88
Eligibility Criteria 89
Studies reporting the effect of patient education interventions on daily PA and/or walking 90 capacity in individuals with PAD and IC, or studies investigating patients' experiences of 91 such interventions were included in this review. Diagnosis of PAD could be objective (eg, an 92 ankle-brachial index (ABI) <0.9), by questionnaire or clinical diagnosis. Original English 93 language research manuscripts in peer review journals and conference proceedings were 94 included. Studies were included only if they reported on structured patient education 95 interventions and/or components particularly related to PAD and IC. For the purposes of this 96 review, the key criteria used to define structured education in diabetes were adopted. 13 To be 97 included, a patient education intervention should: i) aim to empower and inform patients, and 98 to support self-management of their PAD/IC by building sufficient knowledge and skills to 99 do so; ii) include topics about the nature of PAD/IC, and day-to-day living and management 100 of PAD/IC including importance of physical activity and walking; iii) have embedded quality 101 assurance processes including having a structured curriculum, having trained educators, being 102 quality assured, and being audited. 103
Outcomes 104
Daily PA (daily step count and self-reported change in daily PA) was the primary outcomes. 105 Secondary outcomes included treadmill measured walking capacity (absolute claudication 106 distance (ACD)), pain intensity, quality of life, and qualitative data regarding patients' 107 experiences with interventions.
7
A systematic search was conducted in June 2016 (Updated in March 2017). Nine databases 110 (CINAHL, Cochrane Library, Ovid, ProQuest, AMED, MEDLINE, PsycINFO, Web of 111 Science Core Collection, and PEDRO), trial registers and directory of Open-Access 112 repository websites were searched by the first author (UOA) using key words: patient 113 education, lifestyle education, behaviour change intervention, peripheral arterial disease, 114 intermittent claudication, physical activity and homebased exercise combined with specific 115 search terms and strategies for each database. 12 Reference lists of identified studies were also 116 searched. Titles, abstracts and full text of selected studies were independently screened by 117 two authors from a pool of three (UOA, CS, PD) using previously defined eligibility 118 criteria. 12 Differences of opinion regarding inclusion or exclusion were resolved by 119 discussion between authors and reflection in consultation with the second author (PD). 120
Data collection Processes 121
The Cochrane Consumers and Communication Review Group Data Extraction Template, 14 122 and the Supplementary Guidance for Inclusion of Qualitative Research 15 were adapted to 123 extract data from the included studies. The Cochrane Collaboration risk of bias tool was used 124 to determine and summarise risk of the included studies. 16 Assessment was made in each of 125
Study inclusion 134
The search initially identified a total of 5707 studies (Figure 1 
Characteristics of included studies 140
Study design, participants and quality appraisal: Five of the included studies were RCTs, 18-141 22 and one was a pretest-postest design. 32 The number of participants in each study ranged 142 from 23 19 to 882 20 . The basis for IC diagnosis in most (n=4) studies was post exercise 143 ABI≤0.9. 18, 20, 22, 30 Clinical characteristics between the intervention and control groups were 144 similar at baseline for all included studies, except for one study 22 where the control group had 145 a higher resting heart rate and weight (Table 1) . Overall, four of the six trials were rated as 146 high-quality [18] [19] [20] 22 (Table 2) . No study was assessed to have a risk of bias related to selective 147 reporting. Sources of bias in included studies included lack of blinding of outcome 148 assessment (n=5), 18--21, lack of allocation concealment (n=3), 18,19,23 lack of participants and/or 149 personnel blinding (n=3), 21-23 and not being powered to detect an effect size (n=4). 18,19,21,22 150
Components of interventions in included studies 151
The included studies had wide variation in the intervention components used, but all included 152 an education session, exercise prescription, and some behavioural change techniques (BCTs) 153 (Table 1 ). Information provision, goal setting, action planning and feedback were reported in 154 all included studies. Other reported BCTs included motivational interviewing (n=3), barrier 155 identification/problem solving (n=5), feedback on performance (n=2), and prompting self-156 monitoring of behavioural outcome (n=4). Intervention duration ranged from 6 weeks 19 to 4 157 months. 18 Most studies (n=4) instructed patients to walk through moderate-to-severe leg pain.
Control participants either received usual care, 18, 19, 22 an active control (7-minute video) 31 or 159 no intervention. 20 One study did not include a control group. 23 160
Outcomes reported in included studies 161
Five studies 18-20,22,30 reported walking capacity outcomes, and three 18,19,21 reported outcomes 162 of daily PA. Walking capacity outcomes included treadmill walking distances and time, six 163 minutes walking distance, WELCH score, walking impairment questionnaire speed, distance 164 and stair climbing scores. Daily PA was assessed objectively in two studies: daily step counts 165 using a pedometer 18 and accelerometer. 19 
Effect of interventions in included studies 170
Except where specified otherwise, effects of intervention are reported as comparison of the 171 intervention versus the control. 172
Daily physical activity outcomes 173
Self-report daily physical activity outcome. Two studies provided data on self-report of daily 174 PA. 20,21 A high-quality trial, 20 showed no difference between percentage of participants who 175 engaged in walking for recreation ≥3 times per week (36.8 vs 31.4%; p=0.14), engaged in 176 more than usual activity (10.2 vs 9.0%; p=0.73), or belonged to an exercise group (14.0 vs 177 10.1%) at 2-months. However, at 12 months follow up, a greater percentage were walking ≥ 178 3x/week (33.8 vs 25.0%; p=0.01), engaged in more activity than usual (11.1 vs 5.9%; 179 p=0.03), or belonged to an exercise group (16.5 vs 1.8%; p<0.001). The other trial was of 180 low-quality 31 and reported no change in time spent in various levels of activity. 10 increase in daily step count (1575; 95% CI 732 to 2419; p<0.001). In contrast, Tew et al., 19 184 did not find improvement in daily step count of their patients after a six-week intervention 185 (440; 95% CI -827 to1708; p>0.05). 186
Walking capacity 187
Five studies 18-20,22,23 reported outcomes on walking capacity. One pretest-posttest study 23 188 reported significant improvement in ACD: increases of 63% at 3 months, and 84% at 6 189 months compared to baseline. Similarly, one high-quality pilot RCT 19 reported a significant 190 increase in ACD at 6 weeks (173; 95% Cl 23-332) Another high-quality trial 20 found no 191 change in the number of people whose ACD improved, remained same or deteriorated at 2-192 month follow up. However, a significantly greater number of patients were found to have 193 improved their maximum walking distance (p=0.003) at 12 months. 194
Quality of life and other outcomes 195
Five trials, 18-20,22,23 reported outcomes related to quality of life (QoL). Generally, outcomes of 196 both general and disease specific QoL were mixed. One high quality trial showed 197 improvement in SF-36 (0.40 vs -0.30; p=0.002) but no change in ICQ score (p>0.05) at 4 198 months. 18 In contrast, another high quality pilot trial 19 reported improvement in ICQ (-10.6; 199 95% CI -18.9 to -2.3) but not general QoL (EQ-5D utility score 0.05; 95% CI -0.09 to 0.19). al. 25 reported that there is "low-level" evidence that home-based exercise programmes can 262 improve walking capacity and quality of life in patients with IC. However, the reviews were 263 limited to RCTs of BCT, 24 or primarily reported outcomes related to walking capacity rather 264 than daily PA. 24, 25 No review has considered the qualitative experiences of patients with these 265 interventions. Further, although these reviews include studies with patient education 266 modalities, study eligibility did not specifically consider the key criteria for a structured 267 patient education. 13 
268
Possible explanations for the contrasting findings in the current review may be related to the 269 heterogeneity of study design. One 23 of the studies employed a prepost-posttest design 270 therefore lacked a control group, and had high risk of bias including selection, detection, and 271 performance bias. In another trial, 21 it was difficult to completely rule out possible 272 contamination of the control group as both groups received some form of patient education. 273
One study 22 included patients who underwent vascular intervention in the weeks prior to the 274 intervention, and one patient who did not report claudication pain during treadmill testing. The high-quality pilot trial by Tew al al., 19 which applied a 6-week structured education 279 intervention demonstrated potential for increasing PA early in the programme, was 280 particularly rigorous with blinded outcome assessment demonstrating improvement in 281 walking capacity at 6 weeks. Although no change in daily step count was observed, it is possible that the effect of behaviour change interventions takes longer to be noticeable. There 283 could be other factors that mediate a slow response to adapting PA change in patients with 284 PAD and IC even when the disease pathology is understood. One possible barrier is the 285 claudication pain which these patients experience even when they are motivated to walk. 286 Current NICE guidelines recommend "encouraging claudicants to exercise to the point of 287 maximal pain." 7 Perhaps for patients with IC to gain the benefit of secondary prevention, 288 concomitant pain management may be desirable to delay the onset and reduce the intensity of 289 pain. By delaying peak maximal pain and empowering patients through education the 290 potential therapeutic value of walking not only could be realised early in the programme, but 291 may be sustained. or 9 participants in each group and assessed outcomes after just a 6-week intervention. This 320 means that an inadequate sample and early assessment of outcome could limit the statistical 321 power. Thirdly, the time point of outcome assessments were so varied that it was difficult to 322 establish a reference time point to assess outcome performance even in a narrative synthesis. 323
Fourthly, lack of a control group or use of an active control group meant that the specific 324 efficacy of the intervention versus the usual care or nothing could not be clearly ascertained. 
Outcomes assessed at baseline and 14 weeks
Community-based walking exercise with TMC improves ICD and walking performances other than ACD.
Key: IC = intermittent claudication; ABI = Ankle brachial index; RCT; Randomised control trial; ACD = Absolute claudication distance; ICD = Initial claudication distance; NS = not significant, PA= Physical activity, WIQ =walking impairment questionnaire; ICQ = Intermittent claudication questionnaire, EQ-5D = EuroQoL EQ-5D-5L, WELCH = Walking Estimated-Limitation Calculated by History questionnaire Participants valued participation in the intervention because it provided them with greater understanding of their condition (T); Patient valued intervention because it provided them with extra information about their illness(C). 97% were very satisfied with the topic discussed (P) Receiving information about walking
Patients reported that they valued the intervention because it provided them with understanding of the importance of walking(C); Patients reported that they valued the intervention because it provided them with understanding of how walking will help(C); Patient said intervention were worthwhile and that they valued it because it provided them with extra information about walking(C) Being motivation and empowered Patients reported being satisfied with their improvement in attitude towards walking with their claudication and their physical self-confidence (P); Patients reported being satisfied with their improvement in their physical selfconfidence (P); Participants valued participation because it enabled them to walk more (T); Patients said they valued intervention because it provided them with extra encouragement and motivation(C). Benefit of group education session 97% reported that they were very satisfied with the benefit of group education session (P)
Self-monitoring
The use of pedometer was valued as it was seen as useful tool for self-monitoring (T) Goal setting Patient reported that intervention were worthwhile because it provided them clarity on what to do(C); Pedometer as useful tool Patients valued the pedometer and seen as a valuable tool for motivation, self-monitoring and goal setting (T) Receiving personalised care 95.5% reported very satisfied with the scope, quality, and benefit of individual discussion(P); Patients valued the intervention because it provided personalised plan(C) Key: T: Tew et al. 19 
